Navigation Links
invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference

PROficiency™ 2010 is Cornerstone of Ongoing Educational Program on PROs

Pittsburgh, PA (Vocus) February 25, 2010 -- invivodata inc., the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division, PRO Consulting, today opened registration for PROficiency™ 2010 - its 3rd annual educational conference on Patient Reported Outcomes.

Proficiency 2010, the largest conference focused solely on PROs, brings together international professionals involved in the scientific, strategic, operational, and regulatory aspects of PROs in clinical research. The conference agenda features case studies and best practice presentations from international biopharmaceutical researchers on topics related to PRO program and measurement strategy, trial design & execution, and regulatory submissions. Attendees will come away from the conference with more understanding and knowledge to help them:

  • Better differentiate their products by incorporating PROs into the early strategy and endpoint planning phases of their research programs.
  • Understand and comply with the final FDA guidance on the use of PRO in the development of new medical products.
  • Identify, select, and develop PRO instruments that are “fit for purpose” for specific program objectives.
  • Seamlessly incorporate ePRO into clinical trial operations to reduce paper, increase efficiencies, and improve the quality of PRO data collected.

"2010 promises to be the most active year in PRO-related research in a decade," said Doug Engfer, invivodata president and CEO. " Given the FDA's Final PRO Guidance and increasing commercial and governmental market pressures, every biopharma researcher must be on top of the best scientific, regulatory, and delivery practices relating to patient-reported data."

The PROficiency conference is the cornerstone of invivodata's continuing educational program that currently has significant focus on the FDA's final PRO Guidance. In addition to attending the conference, biopharma researchers can also participate in invivodata's 2010 Regulatory Web Seminar series:

   - Final PRO Guidance: Insight from invivodata (Recording of seminar held Jan. 19, 2010)
   - How to Effectively Incorporate PROs into Clinical Trials; March 4, 2010

"Biopharma companies can no longer simply consider using PROs, but must think about how to best measure PROs in their clinical research," said Dr. Jean Paty, Chief Scientist and Regulatory Advisor, PRO Consulting. "PROficiency 2010 and our Web Seminar program will answer researchers' questions about what their organizations must do to conduct compelling PRO research and give them concrete steps to take to successfully define and measure patient reported outcomes."

For additional information and to register for PROficiency 2010 or any of invivodata's Web Seminar programs, visit

About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata’s electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata’s solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata’s solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For additional information, visit

About PRO Consulting
PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has more than 140 years of cumulative experience in psychometrics, PRO study design, migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For additional information, visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
2. invivodata Announces ePROficiency 2009 Web Seminar Series
3. invivodata and PRO Consulting to Present at International Industry Events
4. First Facility to Efficiently Convert Corncobs and Bioenergy Crops to Cellulosic Ethanol Opens
5. OpenQ Announces openSpend for Physician Payment Sunshine Act Compliance
6. New Singapore-French nanotech lab opens at NTU
7. Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches
8. TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products
9. Monsanto Opens First Biotechnology Research Center in China
10. Fraunhofer CSE Opens First Laboratory in Cambridge, MA
11. Harry Guttman Opens Stipkala LLC in Ohio
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology:
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):